Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapy for antibody-mediated rejection in kidney and liver transplant recipients
jRCTs051190074Completed
- Start
- Oct 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of rituximab in humoral rejection. Primary endpoints: Graft survival and Patient survival. Started Oct 2016; status: completed.
02
Drugs
rituximab
03
Conditions
humoral rejection
Beyond the preview
Go deeper on jRCTs051190074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051190074.